CellaVision AB (STU:C26)
€ 18.64 0.88 (4.95%) Market Cap: 454.18 Mil Enterprise Value: 445.31 Mil PE Ratio: 33.07 PB Ratio: 6.46 GF Score: 99/100

CellaVision AB (publ), RAL Diagnostics - M&A Call Transcript

Sep 17, 2019 / 09:00AM GMT
Release Date Price: €34.3 (+15.10%)
Operator

Hello, and welcome to the CellaVision conference call. (Operator Instructions) Today, I am pleased to present CEO, Zlatko Rihter. Please begin your meeting.

Zlatko Rihter;publ;President;CEO
CellaVision AB

()-&

Good morning, everybody. It's Zlatko here from Lund. We also have with me Magnus Blixt, our CFO. So we will lead this session. And thank you all for calling in on this short notice. I know we announced this last afternoon. And today was the (inaudible) and we appreciate that you take your time.

And also of course, this is a big day for CellaVision with this merger or acquisition that we are now announcing. And of course, we'll go through that and try to give you the background. And also hopefully, you'll understand why we'd like to do this.

So we will take you through this step-by-step. And of course, we have a presentation here, so I hope that you all have access to that or can see it online.

So my proposal is then that we move to Slide 2. We'll have 3 topics today. The

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot